References
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. https://doi.org/10.3322/canjclin.55.2.74
- Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
- Korea National Statistical Office. Annual Report on the Cause of Death Statistics 2007. Daejeon: Korea National Statistical Office, 2008.
- Kim YC, Kwon YS, Oh IJ, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer 2007;6:67-73. https://doi.org/10.6058/jlc.2007.6.2.67
- Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 2006;36:216-220. https://doi.org/10.1111/j.1445-5994.2006.01033.x
- Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-2726. https://doi.org/10.1001/jama.291.22.2720
- Jatoi A, Hillman S, Stella P, et al. Should elderly nonsmall- cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005;23:9113-9119. https://doi.org/10.1200/JCO.2005.03.7465
- Woo CM, Kim SY, Lee SA, et al. Paclitaxel for elderly patients with advanced NSCLC. Korean J Med 2006;70:183-189.
- Chen KY, Chen JH, Shih JY, Yang CH, Yu CJ, Yang PC. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors. J Thorac Oncol 2010;5:82-89. https://doi.org/10.1097/JTO.0b013e3181c09b28
- Altundag O, Stewart DJ, Fossella FV, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2007;2:141-146. https://doi.org/10.1097/01.JTO.0000282918.04853.62
- Spaggiari L, Scanagatta P. Surgery of non-small cell lung cancer in the elderly. Curr Opin Oncol 2007;19:84-91. https://doi.org/10.1097/CCO.0b013e32802b7041
- Tuckett AG. Truth-telling in clinical practice and the arguments for and against: a review of the literature. Nurs Ethics 2004;11:500-513. https://doi.org/10.1191/0969733004ne728oa
- Kim HS, Hyun DS, Kim KC, et al. The clinical characteristics and prognosis of elderly patients with lung cancer diagnosed in Daegu and Gyeongsangbukdo. Tuberc Respir Dis 2008;65:15-22. https://doi.org/10.4046/trd.2008.65.1.15
- Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax 1996;51:564-568. https://doi.org/10.1136/thx.51.6.564
- Montella M, Gridelli C, Crispo A, et al. Has lung cancer in the elderly different characteristics at presentation? Oncol Rep 2002;9:1093-1096.
- Langer CJ. Clinical evidence on the undertreatment of older and poor performance patients who have advanced nonsmall- cell lung cancer: is there a role for targeted therapy in these cohorts? Clin Lung Cancer 2011;12:272-279. https://doi.org/10.1016/j.cllc.2011.02.001
- Wong AS, Teo C, Lim SW, Wong E, Soo RA, Chan N. Targeted therapy at the end of life for patients with lung cancer. J Palliat Med 2010;13:945-948. https://doi.org/10.1089/jpm.2010.0084
- Jo KH, An GJ, Kim GM. Future changes and directions for the construction of medical decision-making system in Korea: focused on Delphi Surveys. Korean J Med Ethics Edu 2011;14:131-144.
Cited by
- Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-Small-Cell Lung Cancer in a Tertiary Referral Hospital vol.75, pp.2, 2012, https://doi.org/10.4046/trd.2013.75.2.52